Teleflex Incorporated
TFX
Positions held
Your positionsTFX isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Teleflex operates in the medical instruments and supplies industry, which is experiencing growth due to increasing demand for healthcare services and advancements in medical technology.
- Revenue increased by 4% compared to the prior quarter, reaching $570 million.
- Gross margin improved to 58.2%, up from 56.1% in the previous quarter.
- The company faces challenges with a negative earnings growth rate of -17.3%, indicating potential issues in profitability.
- Teleflex reported a net income of -8.154 million in Q1 2026, highlighting ongoing financial struggles.
- The overall score indicates a 'Sell' signal with a score of -5.00, reflecting negative market sentiment.
Fundamentals
| Market cap | $5.26B | Enterprise value | $7.87B | Trailing P/E | — | Forward P/E | 11.34 |
| PEG | 0.16 | Price / book | 1.81 | Beta | 0.83 | Dividend yield | 1.10% |
| Revenue growth | 28.9% | Earnings growth | -17.3% | Gross margin | 55.1% | Operating margin | 10.1% |
| Profit margin | -45.8% | ROE | -0.7% | ROA | 1.7% | Debt / equity | 1.01 |
| Current ratio | 2.60 | Free cash flow | $179.54M | Analyst recommendation | buy | Mean target | $154.73 |
| 52w high | $145.00 | 52w low | $100.18 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $570M | $548M | -$402M | $913M | $443M |
| Op margin | 12.8% | 6.8% | 41.0% | 12.3% | 23.0% |
| Net income | $99.7M | -$8.2M | -$714M | -$409M | $123M |
| Gross margin | 58.2% | 56.1% | 37.7% | 49.5% | 60.1% |
| Gross profit | $332M | $307M | -$151M | $452M | $266M |
| Operating income | $73.1M | $37.0M | -$165M | $113M | $102M |
- Revenue +4% vs prior quarter ($570M vs $548M).
- Gross margin 58.2% (was 56.1% prior quarter).
- Operating margin expanded to 12.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.7B | $1.7B | $2.8B | — |
| Op margin | 12.8% | 14.9% | 17.7% | 18.4% | — |
| Net income | -$906M | $69.7M | $356M | $363M | — |
| Gross margin | 56.2% | 61.0% | 60.7% | 54.9% | — |
| Gross profit | $1.1B | $1.0B | $1.0B | $1.5B | — |
| Operating income | $256M | $254M | $304M | $514M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Bruker Gains 66.3% in a Year: What's Driving the Rally?
2026-10-07 · Charles River Gains 75.8% in a Year: What's Driving the Rally?
2026-10-07 · Reasons to Add Globus Medical Stock to Your Portfolio Now
2026-10-06 · TFX or SONVY: Which Is the Better Value Stock Right Now?
2026-10-06 · Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
2026-10-02 · 3 Healthcare Stocks That Concern Us
2026-09-30 · Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
2026-09-29 · Stocks making big moves yesterday: TTM Technologies, PacBio, Nvidia, Palo Alto Networks, and Teleflex
2026-09-29 · Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
2026-09-29 · Should New Leadership And Debt Focus At Teleflex (TFX) Require Action From Investors?
2026-09-29 · Why Teleflex (TFX) Stock Is Trading Up Today
Price (daily)
Full chart · RSI · MACD · patterns